No association between a putative functional promoter variant in the dopamine beta-hydroxylase gene and schizophrenia

Psychiatr Genet. 2003 Sep;13(3):175-8. doi: 10.1097/00041444-200309000-00007.

Abstract

Objective: Disturbances in catecholamine transmission have been implicated in schizophrenia. Dopamine beta-hydroxylase catalyses the conversion of dopamine to norepinephrine in noradrenergic cells. We attempted to investigate a putative functional promoter polymorphism in the dopamine beta-hydroxylase gene (DBH) for association with schizophrenia.

Methods: Unrelated schizophrenic patients (n=155) and control subjects (n=436) were analysed with regard to the DBH -1021 C/T variant.

Results: No significant allele or genotype differences were found.

Conclusions: The present results do not support a major involvement of the DBH gene in schizophrenia in the Swedish population investigated.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Dopamine beta-Hydroxylase / genetics*
  • Gene Frequency
  • Genetic Variation*
  • Genotype
  • Humans
  • Polymorphism, Single Nucleotide / genetics*
  • Reference Values
  • Schizophrenia / enzymology
  • Schizophrenia / genetics*
  • Sweden

Substances

  • Dopamine beta-Hydroxylase